SEC Form S-4 filed by SRX Health Solutions Inc.
$SRXH
Beverages (Production/Distribution)
Consumer Staples
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - SRx Health Solutions, Inc. (0001471727) (Issuer)
3 - SRx Health Solutions, Inc. (0001471727) (Issuer)
4 - SRx Health Solutions, Inc. (0001471727) (Issuer)
+5.69% return for shareholders compares to -4.98% decline on the S&P 500 index SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio NORTH PALM BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced returning +5.69% in March 2026 in its hedging pool driven by the EMJX artificial intelligence (AI) engine as compared to a decline of -4.98% on the S&P 500 index. Michael Young, Director of SRx Health, co
NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced hedging its decentralized finance (DeFi) portfolio with investment in Gold. The Company has also reduced its hedge on emerging markets. Michael Young, Director of SRx Health, commented, "We are looking forward to the closing of EMJX in the near future." Additional Information and Where to Find It In connection with the proposed transaction between the Company and EMJX intends to file with the SEC a Registratio
NORTH PALM BEACH, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced entering into a hedged position on its cryptocurrency and emerging markets investment portfolio for volatility protection on digital assets and international revenues. Michael Young, Director of SRx Health, commented, "We look forward to updating the market and our shareholders in the near term on the proposed timeline to close on the EMJX transaction." Forward-Looking StatementsThis press release contains for
S-4 - SRx Health Solutions, Inc. (0001471727) (Filer)
8-K - SRx Health Solutions, Inc. (0001471727) (Filer)
424B3 - SRx Health Solutions, Inc. (0001471727) (Filer)
+5.69% return for shareholders compares to -4.98% decline on the S&P 500 index SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio NORTH PALM BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced returning +5.69% in March 2026 in its hedging pool driven by the EMJX artificial intelligence (AI) engine as compared to a decline of -4.98% on the S&P 500 index. Michael Young, Director of SRx Health, co
Executed Definitive Agreement to Acquire EMJ Crypto Technologies ("EMJX"), a "Gen 2" Digital-Asset Treasury Platform, Anticipated to Close in first half of Calendar 2026 Strengthened Balance Sheet, with $13.1 Million in Cash at Quarter End During and Subsequent to Quarter, Deployed $18 Million Into Bitcoin and Ethereum as part of Digital Treasury Strategy NORTH PALM BEACH, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company" or "SRXH"), a pet health and wellness company, today announced its financial results for the fiscal first quarter 2026 for the three-month period ended December 31, 2025. "Q1 FY26 marked a pivotal reset for the Company," s
EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE:SRXH) (the "Company" or "SRx", previously known as "Better Choice"), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy in our domestic business and have implemented marketing investment shifts to grow brand awareness and discoverability," says Kent Cunningham, CEO of SRx. "We are focused on optimizing our port
TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current
TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited